Jazz Pharmaceuticals plc (JAZZ) › Operating Cash FlowJazz Pharmaceuticals plc (JAZZ) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$15.88M2010: $58.87M2011: $151.60M2012: $249.75M2013: $288.43M2014: $407.61M2015: $531.94M2016: $592.39M2017: $693.09M2018: $798.90M2019: $776.40M2020: $899.65M2021: $778.51M2022: $1.27B2023: $1.09B2024: $1.40B2025: $1.36B$1.36B2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$1.36B-2.9%2024$1.40B+27.8%2023$1.09B-14.1%2022$1.27B+63.4%2021$778.51M-13.5%2020$899.65M+15.9%2019$776.40M-2.8%2018$798.90M+15.3%2017$693.09M+17.0%2016$592.39M+11.4%2015$531.94M+30.5%2014$407.61M+41.3%2013$288.43M+15.5%2012$249.75M+64.7%2011$151.60M+157.5%2010$58.87M+470.8%2009-$15.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share